FENDRR and osteosarcoma: Nonetheless, we found no apparent change in cellular proliferation after gain or loss of lincFOXF1 function, consistent with the findings of a previous study and clinical data showing that lincFOXF1 is not related to tumour size.28, 29 Conversely, a recent study30 reported that overexpression of lincFOXF1 repressed the cell cycle and promoted apoptosis in doxorubicin‐resilient osteosarcoma cells.